Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
复制标题
DOI:
10.1111/j.1539-6924.2011.01652.x
复制
发表时间:
2012-07
期刊:
影响因子:
--
通讯作者:
Gazelle GS
中科院分区:
文献类型:
--
作者:
McMahon PM;Kong CY;Johnson BE;Weinstein MC;Weeks JC;Tramontano AC;Cipriano LE;Bouzan C;Gazelle GS
The natural history model underlying the MGH Lung Cancer Policy Model (LCPM) does not include the two-stage clonal expansion model employed in other CISNET lung models. We used the LCPM to predict numbers of U.S. lung cancer deaths for ages 30–84 between 1975 and 2000 under 4 scenarios as part of the comparative modeling analysis described in this monograph. The LCPM is a comprehensive microsimulation model of lung cancer development, progression, detection, treatment, and survival. Individual-level patient histories are aggregated to estimate cohort or population-level outcomes. Lung cancer states are defined according to underlying disease variables, test results, and clinical events. By simulating detailed clinical procedures, the LCPM can predict benefits and harms attributable to a variety of patient management practices, including annual screening programs. Under the scenario of observed smoking patterns, predicted numbers of deaths from the calibrated LCPM were within 2% of observed over all years (1975–2000). The LCPM estimated that historical tobacco control policies achieved 28.6% (25.2% in men, 30.5% in women) of the potential reduction in U.S. lung cancer deaths had smoking had been eliminated entirely. The hypothetical adoption in 1975 of annual helical CT screening of all persons aged 55–74 with at least 30 pack-years of cigarette exposure to historical tobacco control would have yielded a proportion realized of 39.0% (42.0% in men, 33.3% in women). The adoption of annual screening would have prevented less than half as many lung cancer deaths as the elimination of cigarette smoking.
登录
查看更多内容
DOI:
10.1111/j.1524-4733.2008.00484.x
发表时间:
2009-06
期刊:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
影响因子:
--
作者:
Kong CY;McMahon PM;Gazelle GS
通讯作者:
Gazelle GS
DOI:
10.1111/j.1539-6924.2012.01827.x
发表时间:
2012-07
期刊:
Risk analysis : an official publication of the Society for Risk Analysis
影响因子:
--
作者:
Boer R;Moolgavkar SH;Levy DT
通讯作者:
Levy DT
影响因子:
2.3
作者:
Meza, Rafael;Hazelton, William D.;Moolgavkar, Suresh H.
通讯作者:
Moolgavkar, Suresh H.
影响因子:
3.8
作者:
Rosenberg, Marjorie A.;Feuer, Eric J.;Burns, David M.
通讯作者:
Burns, David M.
影响因子:
3.8
作者:
Holford, Theodore R.;Clarke, Lauren D.
通讯作者:
Clarke, Lauren D.